Latest Cancer Survivorship Programs News

Page 1 of 1

ImpediMed Doubles US Sales, Unlocks $5M Growth Capital Tranche

ImpediMed has doubled its US unit sales in Q4 FY25, achieving a record total contract value and securing an additional $5 million tranche under its growth capital facility.

Ada Torres

16 July 2025

Top